SALARIUS PHARMACEUTICALS INC (SLRX)

US79400X4043 - Common Stock

2.64  -1.03 (-28.07%)

Premarket: 2.8 +0.16 (+6.06%)

Free users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2024-9-30)
2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
Revenue
0.000.000.001.84M5.23M
Cost Of Goods
N/AN/AN/AN/AN/A
Gross Profit
N/AN/AN/AN/AN/A
Operating Expenses
5.22M12.89M22.97M14.65M13.02M
Research and Development
654.63K7.17M15.84M8.55M6.91M
Selling, General, and Administrative Expenses
4.56M5.72M7.14M6.10M6.11M
Operating Income
-5.22M-12.89M-22.97M-12.81M-7.79M
Interest Income/Expense
222.67K352.25K230.00K40.00K260.00K
Other Income/Expense
N/AN/AN/A0.00180.00K
Non Recurring Items
N/A0.00-8.87MN/AN/A
Income Before Taxes
-4.99M-12.54M-31.61M-12.77M-7.35M
Income Tax
N/AN/AN/AN/AN/A
Net Income
-4.99M-12.54M-31.61M-12.77M-7.75M
EBITDA
-5.21M-12.88M-22.96M-12.79M-7.77M
 
Per Share Data
EPS Diluted Total Ops
-8.19-3.84-14.91-7.72-12.50
Non GAAP EPS
N/AN/A-86.40-60.00-110.00
 
Statistics
Gross Profit Margin
N/AN/AN/AN/AN/A
Profit Margin
N/AN/AN/A-694.02%-148.18%
Operating Profit Margin
N/AN/AN/A-696.20%-148.95%

All data in USD

Charts